AN OVERVIEW OF CUBAS BIOTECHNOLOGY INDUSTRY IN THE CONTEXT OF PRO-SOCIETY INNOVATION APPROACH.
- Vocational School of Social Sciences - Marmara University, Turkey.
- Abstract
- Keywords
- References
- Cite This Article as
- Corresponding Author
In innovation theories, market-friendly approaches take attention as the dominant paradigm. Mainstream approaches consider the concepts of technology and innovation as the parameters on the basis of the market. The market-friendly paradigm accepts technology and innovation as a competitive tool in the market economy. However, it arouses curiosity whether a pro-society approach which doesn\'t focus on competition and profit, but instead, prioritizes the needs of the society and the convenience for the society to access the tools to meet such needs, would be possible and rational. An approach integrating the goals to make a contribution to the economic development of the country and to meet social needs, would be distinctive and important. Cuba, which remains behind the developed countries in terms of both economic power and the level of R&D activities, has made a big progress in bio-technology and the pharmaceutical industry, indeed. The purpose of this research is to analyze the effect of society-oriented innovation on these developments.
- Aghion, Phillippe ?Knowledge and Development: A Schumpeterian Approach?, ABCD Conference, 27 June 2000
- Balart, Fidel Castro D?az, Antonio Hidalgo (2015). The Science and Technological Innovation System of Cuba: The Callanges Faced in the Context of Globalisation?, 13th Globelics International Conference,https://www.researchgate.net/publication/283321219_THE_SCIENCE_AND_TECHNOLOGICAL_INNOVATION_SYSTEM_OF_CUBA_THE_CHALLENGES_FACED_IN_THE_CONTEXT_OF_GLOBALISATION
- C?rdenas, Andr?s (2009). ?The Cuban Biotechnology Industry: Innovation and universal health care?, https://pdfs.semanticscholar.org/df8b/95006fb835075a7b50a51cf3f61273b00304.pdf 01.06.2018
- Ernst & Young.(2007), ?Doing Business with Cuba: Update? Cuba Absolutely.;Vol 1:55
- Evenson, Debra (2007). ?Cuba?s Biotechnology Revolution?,MEDICC Review, Fall 2007, Vol 9, No 1
- European Commission, ?Green Paper On Innovation?, December 1995,
- Govindaraj, R. &Chellaraj, G. (2001), ?The pharmaceutical sector in India: Issues and options?, World Bank, Washington, DC.
- Grogg, P. (2001). ? Health Cuba: Nearly 80 Percent of Medicines Produced Locally, InterPress Service, March 19
- Fagerberg, Jan (2003), ?The dynamics of technology, growth and trade: A Schumpeterian perspective?, Working paper nr. 25/2003, https://www.duo.uio.no/bitstream/handle/10852/17734/wp25.pdf?sequence=1 10/09/2018
- Kaplan, Warren and Richard Laing (2005), ?Local Production of Pharmaceuticals: Industrial Policy and Access to Medicines?, Health, Nutrition, and Population Family, (HNP)Discussion Paper
- Sica, Edgardo (2016). Economic Theories of Eco-innovations: A Comparison between the Neoclassical and Evolutionary Approaches?, ?International Journal of Innovation and Sustainable Development ? January
- Statista, ?Biotechnology industry - Statistics & Facts?https://www.statista.com/topics/1634/biotechnology-industry/03/04/2018
- OECD (2005), ?Oslo Manual Guıdelınes For Collecting And Interpreting Innovation Data?, Third edition,
- Tancer, R.S. (1995). ?The Pharmaceutical Industry in Cuba?, Clinical Therapeutics, 17(4): 1-8.
- UN (1992), Convetion on Biological Diversity
- WHO& EC& PAHO (2015),? Cuban experience with local production of medicines, technology transfer and improving access to health?, ISBN 978 92 4 150971 8
- Ruttan (1971). ?Usher and Schumpeter on Invention, Innovation and Technological Change?, The Economics of Technological Change, Harmondsworth:Penguin Books,1971.
[Neslihan Celik. (2018); AN OVERVIEW OF CUBAS BIOTECHNOLOGY INDUSTRY IN THE CONTEXT OF PRO-SOCIETY INNOVATION APPROACH. Int. J. of Adv. Res. 6 (Oct). 1057-1062] (ISSN 2320-5407). www.journalijar.com
